DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @BrainstormCell | 3 |
| @newsfilterio | 2 |
| @otcdynamics | 2 |
| @DHopkins9975 | 2 |
| @StockNewsNow | 1 |
Recent Tweets for BCLI
 |
@dlavoie02 RT @BrainstormCell: Thanks for Voting for @BrainstormCell BUZZ OF BIO! https://t.co/QZs5hHlHN8 $BCLI #NurOwn #ALS #MS #EndALS results soon… December 6th 2019, 9:12pm |
 |
@BrainstormCell Thanks for Voting for @BrainstormCell BUZZ OF BIO! https://t.co/QZs5hHlHN8 $BCLI #NurOwn #ALS #MS #EndALS results s… https://t.co/BxouXHQmoP December 6th 2019, 9:12am |
 |
@cristin187 RT @BrainstormCell: $BCLI proudly presents Poster 153: “MSC-NTF Differentiation Increases the Neurotrophic Effects of MSC Cells: Live Imagi… December 5th 2019, 11:12pm |
|
@BrainstormCell $BCLI proudly presents Poster 153: “MSC-NTF Differentiation Increases the Neurotrophic Effects of MSC Cells: Live I… https://t.co/7X8RdFg5yR December 5th 2019, 4:12pm |
 |
@sunnyberasmus RT @BrainstormCell: $BCLI Dr. Ralph Kern delivered a podium presentation: “Modulation of innate immunity by MSC-NTF (NurOwn®) cells correla… December 4th 2019, 8:12pm |
|
@BrainstormCell $BCLI Dr. Ralph Kern delivered a podium presentation: “Modulation of innate immunity by MSC-NTF (NurOwn®) cells cor… https://t.co/SwtbTSOSP5 December 4th 2019, 4:12pm |
 |
@ArrestALSNow RT @Cylebo: Help us win. Wall Street will listen and learn that there is hope for #ALS and other #CNS diseases $BCLI https://t.co/yvxglKsYee December 3rd 2019, 9:12pm |
 |
@DHopkins9975 @Animal514 much like $BCLI December 3rd 2019, 9:12pm |
 |
@Cylebo Help us win. Wall Street will listen and learn that there is hope for #ALS and other #CNS diseases $BCLI https://t.co/yvxglKsYee December 3rd 2019, 10:12am |
 |
@Gambiste1 RT @fierro7676: $BCLI Stem cells at work on another trial https://t.co/30JfNtNCex November 30th 2019, 7:11pm |
 |
@StockTipRobot You've exceeded your allotted stock tips. Now quit your job and buy Brainstorm Cell Therapeutics Inc. $BCLI #Wallstreet November 30th 2019, 1:11am |
 |
@StockflareUS $BCLI: Forecast sales for Brainstorm Cell Therapeutics Inc are now forecast to rise this year. (https://t.co/84bZx3mH2r) November 28th 2019, 10:11am |
 |
@fierro7676 $BCLI Stem cells at work on another trial https://t.co/30JfNtNCex November 28th 2019, 12:11am |
 |
@otcdynamics $BCLI BrainStorm Cell Therapeutics to make scientific presentations at the 30th International Symposium on ALS/MND https://t.co/c0fKlkWPhx November 26th 2019, 8:11am |
 |
@ez_alertz $BCLI BrainStorm Cell Therapeutics to make scientific presentations at the 30th International Symposium on ALS/MND https://t.co/VcuXxSG4Fj November 26th 2019, 8:11am |
 |
@newsfilterio BrainStorm Cell Therapeutics to make scientific presentations at the 30th International Symposium on ALS/MND $BCLI https://t.co/Q3mmcqNB2Q November 26th 2019, 8:11am |
 |
@dispatchtribune FY2019 EPS Estimates for Brainstorm Cell Therapeutics Inc $BCLI Cut by Zacks Investment Research https://t.co/iVsaKNIY4u November 26th 2019, 1:11am |
 |
@OlympiaReport Brainstorm Cell Therapeutics Inc $BCLI to Post FY2019 Earnings of -$0.93 Per Share, Zacks Investment Research Forec… https://t.co/BhJxyEnlrJ November 26th 2019, 1:11am |
 |
@kyledenis9 RT @kylewdennis: If true, this is huge news for $BCLI. Patient saying he's walking after 1 month of treatment for #ALS in their Phase 3 cli… November 25th 2019, 4:11pm |
 |
@SwingTradeBot 50 DMA Support today: $BCLI ... https://t.co/aW7zteKP9U November 25th 2019, 3:11pm |
 |
@StockNewsNow $BCLI BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site https://t.co/OaTnNyX1dL November 25th 2019, 10:11am |
 |
@PennyStockPlay1 BrainStorm $BCLI Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site #INVESTORS https://t.co/0MWQb42r6K November 25th 2019, 8:11am |
|
@DHopkins9975 $BCLI Anyone know if they’ve utilized any of their ATM financing? I still think cash is their biggest problem. November 25th 2019, 8:11am |
 |
@ZoZoStockwatch $BCLI: BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site November 25th 2019, 6:11am |
|
@otcdynamics $BCLI BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site https://t.co/zmscwuK5YY November 25th 2019, 6:11am |
|
@newsfilterio BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site $BCLI https://t.co/3qQf9Yg8hK November 25th 2019, 6:11am |
 |
@stocknewstimes Brainstorm Cell Therapeutics Inc $BCLI Forecasted to Post FY2019 Earnings of -$0.93 Per Share https://t.co/ki6sMB1Bpn November 25th 2019, 1:11am |
 |
@AmericanBanking Brainstorm Cell Therapeutics Inc $BCLI Forecasted to Post FY2019 Earnings of -$0.93 Per Share https://t.co/xZS4oVZpB4 #stocks November 25th 2019, 1:11am |
 |
@TheMarketsDaily Brainstorm Cell Therapeutics Inc $BCLI Forecasted to Post FY2019 Earnings of -$0.93 Per Share https://t.co/zjhCqoR8NU November 25th 2019, 1:11am |
 |
@ConsumerFeed Brainstorm Cell Therapeutics $BCLI Shares Cross Above Two Hundred Day Moving Average of $3.85 https://t.co/iayCQsDpB8 November 24th 2019, 7:11am |
 |
@ResearchPool $BCLI #Brainstorm Cell Therapeutics BCLI: Phase 3 ALS Trial Fully Enrolled; Phase 2 Results Published in Neurology.… https://t.co/pJ0qiCBM5K November 23rd 2019, 8:11am |
|
@newsfilterio form SC 13D (general statement of acquisition of beneficial ownership) filed with the SEC $BCLI https://t.co/akitnh2n5V November 22nd 2019, 9:11pm |
|
@newsfilterio BrainStorm Cell Therapeutics announced publication $BCLI https://t.co/vjSisUA9e3 November 22nd 2019, 7:11pm |
|
@dispatchtribune Brainstorm Cell Therapeutics $BCLI Stock Passes Above 200 Day Moving Average of $3.85 https://t.co/6EAkJ6HLmr November 22nd 2019, 6:11pm |
|
@Chrissy56516517 RT @otcdynamics: $BCLI BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in https:/… November 21st 2019, 3:11pm |
 |
@AlertTrade RT @SwingTradeBot: 200 DMA Support today: $BCLI ... https://t.co/LjP7KUcNnp November 21st 2019, 2:11pm |
 |
@fintel_io Daly Joseph Patrick has filed a new activist 13D, reporting 4.58% ownership in $BCLI - https://t.co/BvKGrnfKeP November 21st 2019, 11:11am |
 |
@ZacksSmallCap $BCLI: @BrainstormCell - Enrollment Complete for Phase 3 ALS Trial - https://t.co/o290DRJrGn by @DavidBautz https://t.co/iYWvzUhUV7 November 21st 2019, 11:11am |
 |
@Stock_News_Now $BCLI: New SEC Filing for BCLI: Form SC 13D (No. 0001332596-19-000006): https://t.co/QAHyAjLy53 November 21st 2019, 8:11am |
 |
@StockTexts $BCLI Brainstorm Cell Therapeutics Inc. SEC Filing: Form SC 13D https://t.co/KV5EbySpXI November 21st 2019, 7:11am |
 |
@ez_forms $BCLI Daly Joseph Patrick Discloses 4.58% Active Ownership in BRAINSTORM CELL THERAPEUTICS INC. Form: 13D Filing: https://t.co/4GdQqQzXAu November 21st 2019, 7:11am |
 |
@RTFilingsStocks Daly Joseph Patrick files 13D disclosing 4.58% stake in $BCLI https://t.co/MDdWlBMSzR November 21st 2019, 7:11am |
 |
@lanaroad RT @NewsQuantified: $BCLI Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology. BCLI's stock rockets +1… November 21st 2019, 6:11am |
 |
@sandratebarcoll RT @ez_alertz: $BCLI BrainStorm Cell Therapeutics Announces Publication of NurOwn ALS Phase 2 Randomized Clinical Trial Data in Neurology h… November 20th 2019, 7:11pm |
|
@sandratebarcoll RT @moshakes_911: $BCLI BrainStorm Cell Therapeutics Announces Publication of NurOwn ALS Phase 2 Randomized Clinical Trial Data in Neurology November 20th 2019, 7:11pm |
|
@Gambiste1 RT @gcassidy718: $BCLI what a Company 3.84 % change recently https://t.co/s2xV25F2DE November 20th 2019, 6:11pm |
 |
@gcassidy718 $BCLI what a Company 3.84 % change recently https://t.co/s2xV25F2DE November 20th 2019, 5:11pm |
 |
@EliteMedGroup @adamfeuerstein What’s your thoughts on $bcli Phase II Data ? November 20th 2019, 12:11pm |
|
@StockNewsNow $BCLI BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in N… https://t.co/tw1GCMhrkr November 20th 2019, 10:11am |
|
@AlertTrade SOCIAL ACTIVITY: $BCLI - Brainstorm Cell Therapeutics I, Inc ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 20th 2019, 10:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.